Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life
Conclusion: Eribulin is an effective new treatment option in heavily pretreated MBC, with a manageable toxicity profile. Our results confirm that treatment with eribulin is feasible and safe in real-world patients.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Murat Sari P & #305;nar Saip Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Hormones | India Health | Liver | Neurology | Peripheral Neuropathy | Study | Toxicology | Urology & Nephrology